Proven Patency since 2021 - Covera Vascular Covered Stent

AVeNEW is the first large, prospective, randomized trial studying whether a covered stent would provide a benefit compared to PTA for the treatment of AV fistula stenosis.

Proven Patency since 2021.


Do you care about safety profile in AV fistula stenosis?


Register to view the data from 24-months trial and keep up to date with the latest BD updates.



Register to gain access to the AVeNEW 24-month data trial and the opportunity to register your interest for our in-person Masterclass at CIRSE 2024.


BD
BD